Understanding how the spore cell wall of Clostridioides difficile changes during infection
Regulation of spore peptidoglycan modification
This study is looking at how the C. difficile bacteria start to grow in the gut, which is important for stopping infections, and it aims to find ways to prevent these infections from spreading or coming back.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tufts University Boston NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10744773 on NIH RePORTER |
What this research studies
This research investigates the process by which the spore form of the bacterium Clostridioides difficile germinates in the gut, which is crucial for initiating infection. The focus is on understanding the specific modifications that occur in the spore cell wall during this process. By studying these modifications, researchers aim to develop strategies that could prevent the transmission and recurrence of C. difficile infections, which are a significant threat to public health. The approach involves detailed biological assays and analyses of bacterial behavior in the gut environment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at risk of C. difficile infections, particularly those with a history of antibiotic use or gastrointestinal issues.
Not a fit: Patients who do not have risk factors for C. difficile infections or those who are not susceptible to this bacterium may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new methods for preventing C. difficile infections, thereby improving patient outcomes and reducing healthcare burdens.
How similar studies have performed: Previous research has shown success in understanding bacterial spore germination, indicating that this approach has potential for meaningful advancements in infection prevention.
Where this research is happening
Boston, United States
- Tufts University Boston — Boston, United States (Active)
Researchers
- Principal investigator: Shen, Aimee — Tufts University Boston
- Study coordinator: Shen, Aimee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.